Reporting of Harmonising Outcome Measures for Eczema (HOME) core outcome set instruments in randomized clinical trials for systemic treatments in atopic dermatitis
No abstract
Contributors
Megan Lam, Phyllis I Spuls, Yael A Leshem, Louise A A Gerbens, Kim S Thomas, Bernd Arents, Tim Burton, Carsten Flohr, Aaron M Drucker
Publication
Journal: British Journal of Dermatology
Volume: 189
Issue: 4
Pages: 494 - 496
Year: 2023
DOI:
10.1093/bjd/ljad237
Further Study Information
Current Stage:
Completed
Date:
Funding source(s): This work was supported through a UK National Institute for Health Research Career Development Fellowship held by C.F. (CDF-2014-07-037). Knowledge translation components of this work are funded by the Eczema Society of Canada and the Innovation Fund of the Alternate Funding Plan for the Academic Health Sciences Centres of Ontario.
Health Area
Disease Category: Skin
Disease Name: Atopic dermatitis
Target Population
Age Range: Unknown
Sex: Either
Nature of Intervention:
Study Type
- COS uptake study
Method(s)
- Systematic review
We included RCTs with publicly available results in 2018 or after in a living systematic review and network meta-analysis (NMA) of RCTs of systemic treatments for AD. For each included RCT, we evaluated data reported in trial registries, published conference abstracts and peer-reviewed publications.